Skip to content

Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care

Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07349940
Acronym
MEL
Enrollment
1440
Registered
2026-01-20
Start date
2026-02-01
Completion date
2026-09-30
Last updated
2026-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melanoma In Situ, Mole (Dermatology), Skin Cancer, Skin Cancer Prevention, Skin Lesions

Keywords

skin cancer, melanoma, telemedicine tool, skin tumors

Brief summary

The project is a national, prospective, multicenter, single-arm interventional pilot of screening skin tumors in the Czech Republic. The primary aim of the project is to methodically prepare, implement and evaluate a pilot project that will verify the suitability of the proposed procedure of early detection of skin tumors by using a telemedicine tools and setting up and testing new methods and implementation into the system of social health care.

Detailed description

The project is a national, prospective, multicenter, single-arm interventional pilot project for skin tumors screening involving 18 general practitioners and 6 dermatology centers in the Czech Republic. The main objective of the project is the early detection of skin tumors by general practitioners, increasing the efficiency of healthcare, and methodically preparing, implementing, and evaluating the pilot project. The project aims to verify the suitability of the proposed early detection procedure for skin tumors, as well as to establish and test new methods and integrate them into the healthcare system. As part of the project, the procedure will be tested on a sample of approximately 1,440 individuals, which may help validate the use of telemedicine tools in healthcare. A methodology for the use of telemedicine tools will be developed, along with a framework for collaboration between general practitioners and affiliated dermatologists. Systemic changes will be proposed to enhance the efficiency of the screening process. The project is supported by the European Social Fund (Operational Programme Employment Plus) and the state budget of the Czech Republic. It is registered with the Ministry of Labour and Social Affairs of the Czech Republic under ID: CZ.03.02.02/00/22\_005/0002008.

Interventions

DIAGNOSTIC_TESTIntervention with telemedicine tool

The diagnostic management of enrolled patients will be guided by standardized procedures carried out in general practitioners' offices. Physicians will be trained to identify suspicious skin lesions, capture high-resolution images using dermatoscopes, and transfer the data into advanced telemedicine software. The platform, supported by AI-driven algorithms, enables precise risk stratification of lesions and facilitates remote consultation with collaborating dermatologists. Patients with high-risk lesions will be referred to specialized dermatology centers for further examination and intervention. In cases where excision of a lesion is performed, histopathological assessment will be conducted, and results will be systematically recorded within the dedicated telemedicine platform, ensuring secure and efficient information exchange between dermatologists and general practitioners.

Sponsors

Institute of Health Information and Statistics of the Czech Republic
Lead SponsorOTHER_GOV
University Hospital Kralovske Vinohrady
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* at least 1 suspected lession * phototype I or phototype II

Exclusion criteria

* skin lession examination by dermatologist in last 12 months * unsigned consent to participate in the project and consent to the processing of personal data

Design outcomes

Primary

MeasureTime frameDescription
Potential malignanciesFrom enrollment to the end of examination - baseline.Proportion of individuals with a potential presence of malignancy (detected through the telemedicine tool).
Confirmed malignanciesFrom enrollment to the end of diagnosis at 3 months.Proportion of individuals with confirmed potential malignancy by a dermatologist.
Confirmed malignancies by histologyFrom enrollment to the end of diagnosis at 6 months.Proportion of individuals in whom the diagnosis of malignancy was confirmed histologically.

Countries

Czechia

Contacts

CONTACTDagmar Obšilová, Msc
dagmar.obsilova@uzis.cz+420606429382
CONTACTLucie Mandelova, Ph.D.
lucie.mandelova@uzis.cz+420 770190 828
STUDY_DIRECTORPetr Arenberger, prof.

Hospital university Kralovske Vinohrady

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026